You are in: eMedicine Specialties > Emergency Medicine > DERMATOLOGY Dermatitis, ContactArticle Last Updated: Feb 28, 2008AUTHOR AND EDITOR INFORMATIONAuthor: Bradley D Shy, MD, Staff Physician, Department of Emergency Medicine, New York University School of Medicine/Bellevue Hospital Center Coauthor(s): David Todd Schwartz, MD, Associate Professor of Emergency Medicine, New York University School of Medicine; Attending Physician, Department of Emergency Medicine, Bellevue Hospital Center and New York University Medical Center Editors: Mark Louden, MD, FACEP, Assistant Medical Director, Emergency Department, Duke Raleigh Hospital; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Mark W Fourre, MD, Program Director, Department of Emergency Medicine, Maine Medical Center; Associate Clinical Professor, Department of Surgery, University of Vermont School of Medicine; John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center; Barry E Brenner, MD, PhD, FACEP, Program Director, Department of Emergency Medicine, University Hospitals, Case Medical Center Author and Editor Disclosure Synonyms and related keywords: allergic contact dermatitis, ACD, cell-mediated type IV delayed hypersensitivity reaction, contact allergen, contact urticaria, ICD, irritant contact dermatitis, diaper dermatitis, photodermatitis, photoallergic reactions, phototoxic reactions, photodermatitis, poison ivy, poison oak, poison sumac, rhus dermatitis, Toxicodendron, type I IgE-mediated reaction INTRODUCTIONBackgroundContact dermatitis is any inflammatory reaction of the skin that results from direct contact with an offending agent. Most cases of contact dermatitis evaluated in the ED can be classified as allergic contact dermatitis (ACD) or irritant contact dermatitis (ICD). Additional types of contact dermatitis seen in the ED include photodermatitis and contact urticaria. For further information, see Medscape's Allergy Resource Center. PathophysiologyThe main pathologic feature of contact dermatitis is intercellular edema of the epidermis. This initial reaction may result in intraepidermal vesicle and bullae formation in acute cases and papules, scaling, and lichenification in chronic cases. Within the dermal layer, various cells congregate around the dilated capillaries to aid in inflammatory response. ICD results from direct injury to the skin. It affects individuals exposed to specific irritants and generally produces a stinging or burning sensation within seconds of exposure. Alternatively, extended exposure to a mild irritant can cause a chronic form of ICD. In this case, dryness precipitates an erythematous state, which ultimately leads to cracking and the formation of painful fissures. Allergic contact dermatitis affects only individuals previously sensitized to the contactant. It represents a delayed (cell-mediated, type IV) hypersensitivity reaction and classically requires several hours to complete the cascade of cellular immunity before symptoms manifest. FrequencyUnited StatesAmong workers' compensation claims for dermatologic conditions, 90% are for contact dermatitis. Importantly, not all workers are at equal risk. Most workers who present with ICD have a history of atopic dermatitis.1 The greatest single risk for ICD is a history of atopic dermatitis.1 The most common allergens are nickel, potassium dichromate, and paraphenylenediamine. Contact dermatitis is the reason for 4-7% of dermatologic consultations. Hand dermatitis affects 2% of the population at a given time, and 20% of females are affected at least once in their lifetime. Children of persons with contact dermatitis are 60% more likely to have positive patch tests. InternationalContact allergens are the same in Europe as in the Mortality/MorbidityMost cases of contact dermatitis are easily treated, but cases with an unrecognized etiology can result in long-term morbidity. In rare cases, epidermal contact with an allergen results in an immunoglobulin E (IgE)-mediated immediate hypersensitivity reaction causing anaphylactic shock. Anaphylactic shock, if untreated, can result in death. Contact dermatitis can present concomitantly with chemical burns, which can be life-threatening, depending on the severity of exposure. A review of 51 patients with cement exposure found that 34% required eventual dermatologic surgery.3 Climate/weather RaceContact dermatitis is thought to affect whites more frequently than other races. It may be just as common in blacks but more difficult to detect. Fair-skinned redheads are the most vulnerable. SexThe female-to-male ratio is 2:1. Women are at highest risk following childbirth. Age
CLINICALHistory
Physical
CausesCauses of contact dermatitis are classified into 4 groups according to mechanism of response: allergic contact dermatitis, irritant contact dermatitis, photodermatitis, and contact urticaria.
DIFFERENTIALSBites, Insects Cellulitis Dermatitis, Atopic Dermatitis, Exfoliative Erysipelas Erythema Multiforme Herpes Simplex Herpes Zoster Herpetic Whitlow Impetigo Psoriasis Scabies Vulvovaginitis
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Drug Name | Aluminum acetate (Burow solution) |
|---|---|
| Description | Dissolve aluminum acetate tabs in water for a 1:40 solution. |
| Adult Dose | Apply as compress for 20-30 min 4-6 times/d |
| Pediatric Dose | Apply as in adults |
| Contraindications | Documented hypersensitivity |
| Interactions | None reported |
| Pregnancy | A - Fetal risk not revealed in controlled studies in humans |
| Precautions | For external use only |
Topical steroids are the mainstay of treatment of contact dermatitis. Topical agents of medium-to-high strength (class I-IV) should be adequate to treat most cases. In general, ointments are preferred over creams.
| Drug Name | Triamcinolone acetate (Aristocort) |
|---|---|
| Description | Treats inflammatory dermatosis responsive to steroids. Decreases inflammation by suppressing the migration of polymorphonuclear leukocytes and reversing capillary permeability. A moderate potency is available in both ointment (0.1%) and cream (0.5%). |
| Adult Dose | Apply tid initially; reduce as lesions remit |
| Pediatric Dose | Apply as in adults |
| Contraindications | Documented hypersensitivity; fungal, viral, and bacterial skin infections |
| Interactions | None reported |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Multiple complications (eg, severe infections, hyperglycemia, edema, osteonecrosis, myopathy, peptic ulcer disease, hypokalemia, osteoporosis, euphoria, psychosis, myasthenia gravis, growth suppression) may occur; abrupt discontinuation of glucocorticoids may cause adrenal crisis |
| Drug Name | Hydrocortisone valerate 0.2% (LactiCare HC, DermaGel, Cortaid, Dermacort) |
|---|---|
| Description | Lower-potency cream useful on the face. An adrenocorticosteroid derivative suitable for application to skin or external mucous membranes. Has mineralocorticoid and glucocorticoid effects resulting in anti-inflammatory activity. |
| Adult Dose | Apply tid initially; reduce as lesions remit |
| Pediatric Dose | Apply as in adults |
| Contraindications | Documented hypersensitivity; viral, fungal, and bacterial skin infections |
| Interactions | None reported |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Prolonged use, applying over large surface areas, applying potent steroids, and using occlusive dressings may increase systemic absorption of corticosteroids and may cause Cushing syndrome, reversible HPA axis suppression, hyperglycemia, and glycosuria |
Use in severe cases that involve more than 10-20% of total body surface area (TBSA) or bullae. Systemic therapy may also be considered when sleep or activities of daily living are impaired.1 They have both anti-inflammatory (glucocorticoid) and salt-retaining (mineralocorticoid) properties. Glucocorticoids cause profound and varied metabolic effects. In addition, these agents modify the body's immune response to diverse stimuli.
| Drug Name | Prednisone (Deltasone, Orasone, Sterapred) |
|---|---|
| Description | Used for treatment of a variety of diseases, including adrenocortical insufficiency. Prednisone is inactive and must be metabolized to the active metabolite prednisolone. Conversion may be impaired in patients with liver disease. Use for 2-3 weeks with taper. Too short a course results in recurrence of lesions. |
| Adult Dose | 50 mg PO qd for 1 wk; taper by a 10-mg reduction in dose q3d |
| Pediatric Dose | 1 mg/kg PO for 1 wk; taper by a 20% reduction in dose q3d; available in 5 mg/5 mL elixir (prednisolone sodium phosphate); prolonged use in children can suppress growth |
| Contraindications | Documented hypersensitivity; viral, fungal, tubercular skin, or connective tissue infections; peptic ulcer disease; hepatic dysfunction; GI disease |
| Interactions | Coadministration with estrogens may decrease prednisone clearance; concurrent use with digoxin may cause digitalis toxicity secondary to hypokalemia; phenobarbital, phenytoin, and rifampin may increase metabolism of glucocorticoids (consider increasing maintenance dose); monitor for hypokalemia with coadministration of diuretics |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Abrupt discontinuation of glucocorticoids may cause adrenal crisis; hyperglycemia, edema, osteonecrosis, myopathy, peptic ulcer disease, hypokalemia, osteoporosis, euphoria, psychosis, myasthenia gravis, growth suppression, and infections may occur with glucocorticoid use |
These agents may be used as adjuncts to relieve pruritus associated with contact dermatitis.
| Drug Name | Diphenhydramine (Benadryl) |
|---|---|
| Description | Used for the symptomatic relief of allergic symptoms caused by histamine released in response to allergens. |
| Adult Dose | 25-50 mg cap PO q6h prn |
| Pediatric Dose | 5 mg/kg/d (12.5 mg/5 mL elixir) PO divided qid |
| Contraindications | Documented hypersensitivity; glaucoma; prostatic hypertrophy |
| Interactions | Potentiates effect of CNS depressants; because of alcohol content, do not give syrup dosage form to patients taking medications that can cause disulfiramlike reactions |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | May exacerbate angle-closure glaucoma, hyperthyroidism, peptic ulcer, and urinary tract obstruction |
| Drug Name | Hydroxyzine HCl (Atarax, Vistaril) |
|---|---|
| Description | Antagonizes H1 receptors in the periphery and may be used as alternative to diphenhydramine. May also suppress histamine activity in subcortical region of the CNS. Available in 10 mg/5 mL elixir. |
| Adult Dose | 25-50 mg PO tid/qid prn |
| Pediatric Dose | <6 years: 30-50 mg/d PO divided tid >6 years: 50-100 mg/d PO divided tid |
| Contraindications | Documented hypersensitivity |
| Interactions | CNS depression may increase with alcohol or other CNS depressants |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Associated with clinical exacerbations of porphyria (may not be safe for patients with porphyria); ECG abnormalities (alterations in T waves) may occur; may cause drowsiness |
These agents may be used as adjuncts to moisturize dry skin in subacute and chronic contact dermatitis.
| Drug Name | Urea cream (Ureacin, Ureaphil) |
|---|---|
| Description | Promotes hydration and removal of excess keratin in conditions of hyperkeratosis. |
| Adult Dose | Apply to affected area prn |
| Pediatric Dose | Apply as in adults |
| Contraindications | Documented hypersensitivity; viral skin disease |
| Interactions | None reported |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Do not use near eyes; caution if applied to broken or swollen skin |
| Drug Name | Mineral oil (Fleet, Zymenol) |
|---|---|
| Description | Promotes removal of excess keratin in conditions of hyperkeratosis. |
| Adult Dose | Apply to affected area prn |
| Pediatric Dose | Administer as in adults |
| Contraindications | Documented hypersensitivity |
| Interactions | None reported |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Observe for hypersensitivity reactions |
These are the primary agents for diaper dermatitis.
| Drug Name | Zinc oxide paste (Desitin) |
|---|---|
| Description | Provides relief of minor skin irritations. |
| Adult Dose | Not established |
| Pediatric Dose | Apply to affected area after gentle cleansing and drying, between each diaper change |
| Contraindications | Documented hypersensitivity |
| Interactions | None reported |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | Observe for hypersensitivity reactions |
Moisturize dry skin in subacute and chronic contact dermatitis.
| Drug Name | Camphor and menthol (0.5% each) in emollient base (Sarna Anti-Itch) |
|---|---|
| Description | Topical drug combination that consists of mild local anesthetics, counterirritants, and antipruritic formulations. Generally safe and effective for symptomatic relief. |
| Adult Dose | Apply to affected area prn |
| Pediatric Dose | <12 years: Not established >12 years: Apply as in adults |
| Contraindications | Documented hypersensitivity |
| Interactions | None reported |
| Pregnancy | C - Fetal risk revealed in studies in animals but not established or not studied in humans; may use if benefits outweigh risk to fetus |
| Precautions | For external use only; do not apply to eyes |
See Contact Dermatitis for an excellent review of contact dermatitis with a focus on the pediatric population.5
An illustrated summary of contact dermatitis with special attention to the presentation in the ED can be found in the chapter on this disease in Dermatology in Emergency Care by Libby Edwards.4
The authors and editors of eMedicine gratefully acknowledge the contributions of previous author, John A Michael, MD, to the development and writing of this article.
| Media file 1: Contact dermatitis from latex gloves in a health care worker. Note the sharp demarcations at the perimeter of the area of contact. Latex, in this case, is causing a type IV delayed allergic reaction. Like most types of contact dermatitis, the most important treatment is identification and avoidance of the offending agent. | |
![]() | View Full Size Image | Media type: Photo |
| Media file 2: Contact dermatitis on the thigh of a recreational jogger after a long run. This individual noted running through shrubs, which likely caused the rash. The linear plaques and confluent vesicles and papules on the inferior aspect of the thigh are a common presentation of rhus dermatitis. Image courtesy of Julie Cantatore. | |
![]() | View Full Size Image | Media type: Photo |
| Media file 3: Subacute contact dermatitis, in this case due to bacitracin. Image courtesy of Julie Cantatore. | |
![]() | View Full Size Image | Media type: Photo |
| Media file 4: Contact dermatitis with bullous formation caused in this case by a new pair of shoes. Image courtesy of Julie Cantatore. | |
![]() | View Full Size Image | Media type: Photo |
Article Last Updated: Feb 28, 2008